DS-8500a + Rosuvastatin

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Drug Pharmacokinetics in Healthy Volunteers

Conditions

Drug Pharmacokinetics in Healthy Volunteers

Trial Timeline

May 12, 2015 โ†’ Jul 6, 2015

About DS-8500a + Rosuvastatin

DS-8500a + Rosuvastatin is a phase 1 stage product being developed by Daiichi Sankyo for Drug Pharmacokinetics in Healthy Volunteers. The current trial status is completed. This product is registered under clinical trial identifier NCT03699774. Target conditions include Drug Pharmacokinetics in Healthy Volunteers.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT03699774Phase 1Completed